Community Acquired Pneumonia in Telemark and Ostfold

Community Acquired Pneumonia Clinical Trial

— CAPITO  

Official title:

Prevalence of Legionella Infections, Bacterial Etiology in Pneumonia Among Patients Admitted to Hospital,- and Risk Factors/Characteristics for These Patients.(Translated From Norwegian)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00467701
• Other study ID #: STHF 5690.10
• Secondary ID: NSD: 16388REK: S
• Status: Completed
• Phase: N/A
• First received: April 30, 2007
• Last updated: January 16, 2009
• Start date: May 2007
• Est. completion date: February 2008

Study information

• Verified date: January 2009
• Source: Sykehuset Telemark
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Directorate of HealthNorway:National Committee for Medical and Health Research Ethics
• Study type: Observational

Clinical Trial Summary

The aim of the study is to investigate the bacterial causes in community acquired pneumonia in adults admitted to hospital in two counties in Norway and to look at possible factors that makes the patients susceptible to pneumonia.

Description:

In Norway there is little knowledge of which bacterias that causes pneumonia in patients admitted to hospital. There are also few registered cases of Legionnaires disease every year, compared to our neighbour countries.

Therefore 500 patients with community acquired pneumonia admitted to Telemark hospital and Ostfold hospital in Norway will be tested by urin antigen test for the detection of Legionella pneumophila serogroup 1 and Streptococcus pneumoniae. We will also perform routine bacterial culture of sputum and culture on medium for isolation of Legionella species. A throat swab from the patients will be tested for Mycoplasma pneumoniae, Chlamydophila pneumoniae and Bordetella pertussis using PCR-techniques. Legionella-serology will also be performed. In addition all the included patients are invited to fill in a questionnaire in order to look for risk factors for developing community acquired pneumonia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 380
• Est. completion date: February 2008
• Est. primary completion date: February 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Symptoms of lower airway infection and radiologic sings of pneumonia.

Exclusion Criteria:

• Age<18

• Serious psychiatric illness

• Mentally retarded

• Hospitalized last 14 days

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Community Acquired Pneumonia
• Pneumonia

Locations

Country	Name	City	State
Norway	Sykehuset Telemark	Skien	Telemark

Sponsors (2)

Lead Sponsor	Collaborator
Sykehuset Telemark	Sykehuset Ostfold

Country where clinical trial is conducted

Norway,